NASDAQ:HPTX

(HPTX) (HPTX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
786,899 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
HPTX stock logo

About (HPTX) Stock (NASDAQ:HPTX)

Horizon Therapeutics, Inc., formerly Hyperion Therapeutics, Inc., is a biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat disorders in the areas of orphan diseases. The Company's products include RAVICTI (glycerol phenylbutyrate) oral liquid, BUPHENYL and AMMONAPS (sodium phenylbutyrate) tablets and powder. The Company's products are used to lower ammonia in the blood. RAVICTI is used to treat urea cycle disorders (UCD). BUPHENYL is indicated as an adjunctive therapy in the chronic management of patients with UCDs involving deficiencies of carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS). The Company sells BUPHENYL under the brand name AMMONAPS in Europe and the Middle East.

HPTX Stock News Headlines

“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
“Retirement Secret” Showed 995% Gain Last Time We Shared It
Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.
ESA confirms cancellation of E3 2023
These Are the 12 Best Picnic Spots in Dallas
This Week's Dallas Area Events
See More Headlines
Receive HPTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (HPTX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/26/2015
Today
4/26/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:HPTX
CUSIP
44915N10
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

HPTX Stock Analysis - Frequently Asked Questions

How were (HPTX)'s earnings last quarter?

(HPTX) (NASDAQ:HPTX) issued its quarterly earnings results on Thursday, February, 26th. The biopharmaceutical company reported $0.47 EPS for the quarter, beating the consensus estimate of ($0.20) by $0.67. The biopharmaceutical company had revenue of $30.80 million for the quarter, compared to analyst estimates of $24.60 million. (HPTX)'s revenue was up 65.6% compared to the same quarter last year.

What other stocks do shareholders of (HPTX) own?
This page (NASDAQ:HPTX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners